Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| LCL521 | C31H52N4O7 | 1226851-11-1 | Details |
| LCL521 dihydrochloride；1,3DMG-B13 dihydrochloride | C31H53ClN4O7 | 1226759-47-2 | Details |
| Lefamulin acetate；BC-3781 acetate | C30H49NO7S | 1350636-82-6 | Details |
| Leptomycin A | C32H46O6 | 87081-36-5 | Details |
| LEQ506；NVP-LEQ506 | C25H32N6O | 1204975-42-7 | Details |
| Lesopitron dihydrochloride；E4424 | C15H22Cl2N6 | 132449-89-9 | Details |
| Rivaroxaban；BAY 59-7939 | C19H18ClN3O5S | 366789-02-8 | Details |
| Leu-AMS | C16H25N7O7S | 288591-93-5 | Details |
| Levomecol | C16H18Cl2N4O7 | 118573-58-3 | Details |
| Levothyroxine acyl glucuronide；Thyroxine acyl-β-D-glucuronide | C21H19I4NO10 | 909880-81-5 | Details |
| LG-100064 | C23H26O3 | 153559-46-7 | Details |
| LGD-6972 | C43H46N2O5S | 1207989-09-0 | Details |
| LHVS | C28H37N3O5S | 170111-28-1 | Details |
| Liarozole dihydrochloride；R75251 dihydrochloride | C17H14Cl2N4 | 1883548-96-6 | Details |
| Licorice glycoside C2 | C36H38O16 | 202657-55-4 | Details |
| Lignin；Lignine | unspecified | 9005-53-2 | Details |
| Rofecoxib；MK 966;MK-0966 | C17H14O4S | 162011-90-7 | Details |
| LIN28 inhibitor LI71 | C21H21NO3 | 1357248-83-9 | Details |
| Lin28-let-7a antagonist 1 | C31H29N5O7 | 2024548-03-4 | Details |
| Linaclotide | C59H79N15O21S6 | 851199-59-2 | Details |
| Linezolid-d3；PNU-100766 D3;Linezolid D3 | C16H20FN3O4 | 1127120-38-0 | Details |
| LIT-001 free base | C28H33N7O2S | 2245072-20-0 | Details |
| LIT-001 | C30H34F3N7O4S | 2245072-21-1 | Details |
| Lith-O-Asp | C28H45NO6 | 881179-02-8 | Details |
| Litronesib Racemate；LY-2523355 Racemate;KF-89617 Racemate | C23H37N5O4S2 | 546111-97-1 | Details |
| Litronesib；KF-89617;LY-2523355 | C23H37N5O4S2 | 910634-41-2 | Details |
| Ifenprodil Tartrate | C25H33NO8 | 23210-58-4 | Details |
| LM-1484 | C28H24N4O3 | 197506-02-8 | Details |
| LM11A-31 dihydrochloride | C12H26ClN3O2 | 1243259-19-9 | Details |
| LMD-009 | C29H33N3O3 | 950195-51-4 | Details |
| Iptacopan；LNP023 | C25H30N2O4 | 1644670-37-0 | Details |
| Lodelaben；Declaben;SC-39026 | C25H41ClO3 | 111149-90-7 | Details |
| Loperamide-d6 hydrochloride；R-18553 D6 hydrochloride;Loperamide D6 hydrochloride | C29H34Cl2N2O2 | 1189469-46-2 | Details |
| Lorglumide sodium salt；CR-1409 sodium salt | C22H33Cl2N2NaO4 | 1021868-76-7 | Details |
| Losartan (D4 Carboxylic Acid)；E-3174 D4;EXP-3174 D4 | C22H21ClN6O2 | 1246820-62-1 | Details |
| Bifonazole；Bay H-4502 | C22H18N2 | 60628-96-8 | Details |
| Losartan D4；DuP-753 D4 | C22H19ClD4N6O | 1030937-27-9 | Details |
| Loteprednol Etabonate D5 | C24H31ClO7 | 2026643-11-6 | Details |
| LMP744；MJ-III65;NSC706744 | C24H24N2O7 | 308246-52-8 | Details |
| LMP744 hydrochloride；NSC706744 hydrochloride;MJ-III65 hydrochloride | C24H25ClN2O7 | 308246-57-3 | Details |
| Lp-PLA2-IN-2 | C19H23FN2O4S | 2071636-15-0 | Details |
| Lp-PLA2-IN-3 | C20H13ClF3N3O3S | 2196245-16-4 | Details |
| LPA2 antagonist 2 | C20H16N2O6 | 36840-10-5 | Details |
| LpxH-IN-AZ1 | C21H22F3N3O3S | 901260-40-0 | Details |
| LR-90 | C35H34Cl2N4O8 | 245075-84-7 | Details |
| LRRK2 inhibitor 1 | C20H23N5O4 | 1802525-61-6 | Details |
| LS-102 | C24H36N8O | 1456891-34-1 | Details |
| Mizoribine；NSC 289637;Bredinin;HE 69 | C9H13N3O6 | 50924-49-7 | Details |
| LSD1-IN-5 | C15H13BrN2O3 | 2035912-55-9 | Details |
| LSD1-IN-6 | C15H13BrN2O3 | 2035912-43-5 | Details |
| Pulrodemstat benzenesulfonate；LSD1-IN-7 benzenesulfonate;CC-90011 benzenesulfonate | C30H29F2N5O5S | 2097523-60-7 | Details |
| Pulrodemstat Methylbenzenesulfonate；LSD1-IN-7 Methylbenzenesulfonate | C31H31F2N5O5S | 2097523-57-2 | Details |
| LSN 3213128 | C17H16FN3O4S2 | 1941211-99-9 | Details |
| LSP-249 | C24H22ClN5O | 1801253-04-2 | Details |
| LTβR-IN-1 | C18H16N4O2 | 2189366-77-4 | Details |
| LtaS-IN-1 | C24H17N3O5 | 877950-01-1 | Details |
| LTV-1 | C26H20N2O5S | 347379-29-7 | Details |
| Milnacipran hydrochloride；Dalcipran;Milnacipran HCl;Savella | C15H23ClN2O | 101152-94-7 | Details |
| Ludaconitine | C32H45NO9 | 82144-72-7 | Details |
| Lumefantrine-d18；Lumefantrine D18;Benflumetol D18 | C30H14Cl3D18NO | 1185240-53-2 | Details |
| Lurasidone metabolite 14326 | C28H36N4O3S | 186204-33-1 | Details |
| Lusaperidone；R107474 | C22H21N3O2 | 214548-46-6 | Details |
| Luteolin-7-rutinoside | C27H30O15 | 20633-84-5 | Details |
| Telotristat ethyl；LX1606 | C27H26ClF3N6O3 | 1033805-22-9 | Details |
| LXH254 | C25H25F3N4O4 | 1800398-38-2 | Details |
| LXRβ agonist-2 | C32H31F6N3O7 | 1949801-52-8 | Details |
| Cefmenoxime hydrochloride；Cefmenoxime hemihydrochloride;SCE-1365 hemihydrochloride | C16H18ClN9O5S3 | 75738-58-8 | Details |
| LY-2584702 hydrochloride | C21H20ClF4N7 | 1082948-81-9 | Details |
| IDO1-IN-5 | C23H25FN2O3 | 2166616-75-5 | Details |
| LY 344864 S-enantiomer | C21H22FN3O | 186544-27-4 | Details |
| LY-411575 isomer 1 | C26H23F2N3O4 | 209984-58-7 | Details |
| LY 541850 | C9H13NO4 | 852679-76-6 | Details |
| Pomaglumetad methionil anhydrous；LY2140023 | C12H18N2O7S2 | 635318-55-7 | Details |
| LY2365109 hydrochloride | C22H28ClNO5 | 1779796-27-8 | Details |
| LY2444296；FP3FBZ | C24H22F2N2O2 | 1346133-11-6 | Details |
| Metamizole sodium hydrate；Dipyron hydrate;Analgin;Sulpyrine | C13H20N3NaO5S | 5907-38-0 | Details |
| LY285434 | C23H25N5O2 | 159748-08-0 | Details |
| LY3020371 hydrochloride | C15 H15 F2 N O5 S . Cl H | 1377615-44-5 | Details |
| LY3154207 | C24H29Cl2NO3 | 1638667-79-4 | Details |
| LY88074 Methyl ether | C22H16O4S | 63675-88-7 | Details |
| LY88074 Trimethyl ether | C24H20O4S | 63675-87-6 | Details |
| LY88074 | C21H14O4S | 177744-96-6 | Details |
| Lyn-IN-1；Bafetinib analog | C30H31F3N8O | 887650-05-7 | Details |
| Lys-SMCC-DM1；Lys-Nε-MCC-DM1 | C53H75ClN6O15S | 1281816-04-3 | Details |
| Lysipressin；Lysine vasopressin;[Lys8]-Vasopressin | C46H65N13O12S2 | 50-57-7 | Details |
| LysRs-IN-1 | C7H7N5O3 | 281676-77-5 | Details |
| Metamizole sodium；Dipyron;Analgin | C13H16N3NaO4S | 68-89-3 | Details |
| Protoporphyrin IX；PPIX | C34H34N4O4 | 553-12-8 | Details |
| LysRs-IN-2 | C17H16F3NO4 | 2170696-76-9 | Details |
| LY 222306 | C19H23N5O7 | 154446-98-7 | Details |
| LY 254155 | C19H23N5O6S | 135503-67-2 | Details |
| Methyl-3β-hydroxycholenate | C25H40O3 | 20231-57-6 | Details |
| M3258；LMP7-IN-1 | C17H20BNO5 | 2285330-15-4 | Details |
| M?89 | C37H47N5O4S | 2363165-42-6 | Details |
| m-Nifedipine | C17H18N2O6 | 21881-77-6 | Details |
| M2 ion channel blocker | C18H27N3O2 | 1190215-03-2 | Details |
| M2698；MSC2363318A | C21H19ClF3N5O | 1379545-95-5 | Details |
| M2N12 | C20H16ClN5O2 | 2376577-06-7 | Details |
| Clomiphene citrate；NSC 35770;Clomifene citrate | C32H36ClNO8 | 50-41-9 | Details |
| M8891 | C20H17F2N3O3 | 1464842-09-8 | Details |
| Product Total： Product Page： | ||||
| 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 | ||||